$0.2514
0.002400.96%
At close: -
$0.2500
-0.00140-0.56%
After Hours: 7:53 PM EDT
Cellectar Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cellectar Biosciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-18 | $-0.40 | $-0.37 | -8.11 % |
Q2 | 2024-10-29 | $-0.18 | $-1.00 | 82.0 % |
Q1 | 2024-05-14 | $-0.74 | $-0.72 | -2.78 % |
Q4 | 2024-03-27 | $-0.40 | $-0.59 | 32.2 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Cellectar Biosciences (CLRB) is scheduled to report earnings on March 26, 2025. The last reported earnings were for reported on November 18, 2024 for Q3.
The Actual EPS was $-0.40, which missed the estimate of $-0.37.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.